Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance

Published:2020-01 Issue: Volume:48 Page:100663
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Narayanan Silpa,Cai Chao-Yun,Assaraf Yehuda G.,Guo Hui-Qin,Cui Qingbin,Wei Liuya,Huang Juan-Juan,Ashby Charles R.,Chen Zhe-Sheng

Funder

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University and the National Institute of Health - USA

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference269 articles.

1. The proteasome: a suitable antineoplastic target;Adams;Nat. Rev. Cancer,2004

2. Caspase-dependent inactivation of proteasome function during programmed cell death in Drosophila and man;Adrain;J. Biol. Chem.,2004

3. Primary structures of two homologous subunits of PA28, a γ-interferon-inducible protein activator of the 20S proteasome;Ahn;FEBS Lett.,1995

4. Salinosporamide A (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down-modulation of NF-kappaB regulated gene products;Ahn;Blood,2007

5. Mechanisms of acquired tumor drug resistance;Aleksakhina;Biochim. Biophys. Acta - Rev. Cancer,2019

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Berbamine promotes ferroptosis of esophageal squamous cell carcinoma by facilitating USP51-mediated GPX4 ubiquitination and degradation;Biomedicine & Pharmacotherapy;2024-10

2. ITCH inhibits alkaliptosis in human pancreatic cancer cells through YAP1-dependent SLC16A1 activation;The International Journal of Biochemistry & Cell Biology;2024-10

3. NEK6 dampens FOXO3 nuclear translocation to stabilize C-MYC and promotes subsequent de novo purine synthesis to support ovarian cancer chemoresistance;Cell Death & Disease;2024-09-10

4. Focus on cuproptosis: Exploring new mechanisms and therapeutic application prospects of cuproptosis regulation;Biomedicine & Pharmacotherapy;2024-09

5. Cancer plasticity in therapy resistance: Mechanisms and novel strategies;Drug Resistance Updates;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3